Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Marimed Inc (MRMD)

Marimed Inc (MRMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 198,017
  • Shares Outstanding, K 338,490
  • Annual Sales, $ 121,460 K
  • Annual Income, $ 7,220 K
  • 60-Month Beta 3.27
  • Price/Sales 1.67
  • Price/Cash Flow 8.07
  • Price/Book 4.65
Trade MRMD with:
  • Price/Earnings ttm 30.00
  • Earnings Per Share ttm 0.02
  • Most Recent Earnings 0.01 on 05/10/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 0.01
  • Number of Estimates 1
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year 0.02
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5500 +6.36%
on 05/10/22
0.7050 -17.02%
on 04/26/22
-0.1210 (-17.14%)
since 04/25/22
3-Month
0.4000 +46.25%
on 03/23/22
0.7850 -25.48%
on 03/03/22
-0.1650 (-22.00%)
since 02/25/22
52-Week
0.4000 +46.25%
on 03/23/22
1.2000 -51.25%
on 06/03/21
-0.4450 (-43.20%)
since 05/25/21

Most Recent Stories

More News
MariMed Receives Media Awards For “World’s Largest Cannabis Brownie” PR Campaign

NORWOOD, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator, today...

MRMD : 0.5850 (-2.50%)
MariMed Awarded Dispensary License in Ohio

NORWOOD, Mass., May 18, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused...

MRMD : 0.5850 (-2.50%)
MariMed Strengthens Executive Leadership Team To Support Accelerated Long-Term Growth

Jon Levine Elevated to Chief Administration OfficerSusan Villare Appointed Chief Financial Officer NORWOOD, Mass., May 12, 2022 (GLOBE NEWSWIRE) --...

MRMD : 0.5850 (-2.50%)
MariMed Reports First Quarter 2022 Earnings

Revenue Grew 27% Year Over Year Non-GAAP Adjusted EBITDA Grew 29% Year Over Year Company Maintains Full Year 2022 Guidance NORWOOD, Mass., May 10,...

MRMD : 0.5850 (-2.50%)
MariMed Closes Acquisition of Illinois Craft Cannabis License Allowing for Vertically Integrated Operations

NORWOOD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator...

MRMD : 0.5850 (-2.50%)
MariMed Announces Participation In Upcoming Conferences and Events

NORWOOD, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator...

MRMD : 0.5850 (-2.50%)
MariMed Completes Acquisition of Kind Therapeutics USA, a Maryland Vertically Integrated Cannabis Business

NORWOOD, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator...

MRMD : 0.5850 (-2.50%)
MariMed Receives Maryland State Approval for Transfer of Ownership of Kind Therapeutics USA

NORWOOD, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator...

MRMD : 0.5850 (-2.50%)
MariMed Announces First Quarter 2022 Earnings Date

NORWOOD, Mass., April 12, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator...

MRMD : 0.5850 (-2.50%)
MariMed Files Preliminary Non-Offering Prospectus And Applies For Dual Listing on Canadian Securities Exchange

NORWOOD, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator...

MRMD : 0.5850 (-2.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.6500
2nd Resistance Point 0.6350
1st Resistance Point 0.6100
Last Price 0.5850
1st Support Level 0.5700
2nd Support Level 0.5550
3rd Support Level 0.5300

See More

52-Week High 1.2000
Fibonacci 61.8% 0.8944
Fibonacci 50% 0.8000
Fibonacci 38.2% 0.7056
Last Price 0.5850
52-Week Low 0.4000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar